HIGHLIGHTS
- who: Xiaojie Xia et al. from the Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Guangzhou Road, Nanjing, China have published the research work: Consolidation Chemotherapy Rather than Induction Chemotherapy Can Prolong the Survival Rate of Inoperable Esophageal Cancer Patients Who Received Concurrent Chemoradiotherapy, in the Journal: (JOURNAL)
- what: The study provides the opposite conclusion: the IC + CRT group receiving paclitaxel or raltitrexed in combination with platinum did not have a significant improvement in OS (p=0.114). In terms of side effects, the study provided similar results to previous reports . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.